glp-1 receptor agonists and cancer risk in adults with obesity Breast Cancer: A New Frontier in Prognosis Management Patients taking GLP-1 receptor agonists
Description
3,130,219 GLP-1 also activates PKA and EPAC through a cAMP-dependent pathway
Intra-islet insulin suppresses glucagon release via GABA-GABAA receptor system
doi: 10.3389/fddev.2024.1456654 Received 28 June 2024 Accepted 14 October 2024 Published 06 November 2024 Volume 4 - 2024 Edited by Rakesh Patel, Shree S K Patel College of Pharmaceutical Education and Research Ganpat University, India Reviewed by Fiona McCartney, University College Dublin, Ireland Samar ISSA, cole de Biologie Industrielle, France Updates Copyright 2024 New, Bogus, Travers, Hahn, Vaiceliunaite, Burnet, Wang and Wen
454,455,456 MMPs are a class of enzymes that play a crucial role in the breakdown of extracellular matrix components
[DOI] [PMC free article] [PubMed] [Google Scholar] 274.Gorboulev V., Schurmann A., Vallon V., Kipp H., Jaschke A., Klessen D
Both cause similar side effects, primarily gastrointestinal issues like nausea, diarrhea, and constipation
